Such observations have provided insight into the potential use of various interventions such as AGE inhibitors, RAGE antagonists, and antioxidants in mitigating the detrimental effects of the AGE–RAGE-associated signal transduction pathway in cardiovascular disease [80,81,82,83,84]. This evidence concerns the gene AGER and cardiovascular disorder.